Oxybutynin and Tolterodine for Treatment of Neurogenic Detrusor Overactivity: A Pharmacoeconomic Evaluation in the Brazilian Context. Braz. J. Pharm. Sci. 2012, 48 (2), 227-236. https://doi.org/10.1590/S1984-82502012000200006.